KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Return on Equity (2016 - 2025)

Amgen has reported Return on Equity over the past 17 years, most recently at 0.84% for Q4 2025.

  • Quarterly results put Return on Equity at 0.84% for Q4 2025, up 23.0% from a year ago — trailing twelve months through Dec 2025 was 0.84% (up 23.0% YoY), and the annual figure for FY2025 was 1.06%, up 39.0%.
  • Return on Equity for Q4 2025 was 0.84% at Amgen, up from 0.82% in the prior quarter.
  • Over the last five years, Return on Equity for AMGN hit a ceiling of 3.94% in Q2 2022 and a floor of 0.57% in Q2 2024.
  • Median Return on Equity over the past 5 years was 0.91% (2023), compared with a mean of 1.18%.
  • Biggest five-year swings in Return on Equity: skyrocketed 329bps in 2022 and later plummeted -263bps in 2023.
  • Amgen's Return on Equity stood at 0.79% in 2021, then soared by 127bps to 1.79% in 2022, then tumbled by -46bps to 0.97% in 2023, then tumbled by -37bps to 0.61% in 2024, then skyrocketed by 38bps to 0.84% in 2025.
  • The last three reported values for Return on Equity were 0.84% (Q4 2025), 0.82% (Q3 2025), and 0.97% (Q2 2025) per Business Quant data.